Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update May 18, 2022
Ceapro Inc. to Present PGX Enabling Technology Case Study at the 13th International Symposium on Supercritical Fluids May 13, 2022
Ceapro Inc. Announces Publication of Results for PGX-Processed Alginates in the Journal of CO2 Utilization May 11, 2022
Ceapro Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights April 13, 2022
Ceapro Signs Exclusive Long-Term Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise March 10, 2022
Ceapro Bolsters Board of Directors with Appointment of Top Executive from Global Pharmaceutical Industry March 2, 2022
